- Director, Proteomics Services Facility, University of Illinois at Chicago
Proteomics Services Facility
University of Illinois at Chicago
835 South Wolcott Avenue
Chicago, IL 60612
Phone: 312 996 7880
Fax: 312 996 7880
The Proteomics and Informatics Services Facility provides investigators affiliated with CBC member institutions access to a number of mass spectrometers optimized for use in proteomics studies. The facility operates by syndicating the responsibility for the provision, operation and maintenance of these mass spectrometers to the RRC’s Mass Spectrometry Laboratory (MSL) and by syndicating sample preparation and fractionation activities to the RRC Protein Laboratory (PL). Scientists from these laboratories work together in conjunction with informatics specialists directly employed by the Proteomics facility to provide investigators with a range of services utilizing the combined capabilities of these laboratories.
Scientists employed and affiliated with the PSF can design and conduct experimental protocols, reduce and interpret data and provide pre-experimental consultation to investigators who seek to incorporate proteomic experimental strategies into their research programs. Researchers may submit samples to the facility for protein separation, post separation processing, mass spectroscopy and data analysis. Alternatively, qualified users may schedule instrument time to analyze their own samples. Two BioWorks workstations and one with Mascot and additional proteomics software may be scheduled for use. Please follow the links on the left for an online order page, scheduling various instruments, and a resource page to help you with protein purification.
The PSF also maintains close ties with investigators at UIC and other CBC member institutions (University of Chicago and Northwestern University) who specialize in Mass Spectrometry and Informatics research in order to provide opportunities for advanced collaboration, research referrals and protocol development.
The Proteomics and Informatics Services Facility was established by a grant from The Searle Funds at The Chicago Community Trust to the Chicago Biomedical Consortium.